SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 201 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $225,785 | -81.1% | 376,433 | -59.0% | 0.00% | -100.0% |
| Q2 2023 | $1,192,690 | +219548.3% | 917,454 | +197.6% | 0.00% | – |
| Q1 2023 | $543 | -18.5% | 308,333 | +45.4% | 0.00% | – |
| Q4 2022 | $666 | -100.0% | 212,009 | -66.1% | 0.00% | -100.0% |
| Q3 2022 | $3,063,000 | -38.7% | 625,197 | -48.2% | 0.00% | -33.3% |
| Q2 2022 | $4,994,000 | +24.4% | 1,206,252 | +74.7% | 0.00% | +50.0% |
| Q1 2022 | $4,013,000 | -59.0% | 690,627 | -47.0% | 0.00% | -60.0% |
| Q4 2021 | $9,779,000 | +443.6% | 1,303,854 | +553.2% | 0.01% | +400.0% |
| Q3 2021 | $1,799,000 | -4.8% | 199,619 | +26.5% | 0.00% | 0.0% |
| Q2 2021 | $1,889,000 | +30.0% | 157,851 | +36.1% | 0.00% | 0.0% |
| Q1 2021 | $1,453,000 | -50.7% | 115,973 | -38.6% | 0.00% | -50.0% |
| Q4 2020 | $2,949,000 | -43.3% | 188,967 | -65.7% | 0.00% | -66.7% |
| Q3 2020 | $5,204,000 | -45.1% | 550,732 | -63.0% | 0.01% | -71.4% |
| Q1 2020 | $9,479,000 | +9014.4% | 1,488,020 | +13574.1% | 0.02% | – |
| Q1 2019 | $104,000 | -98.7% | 10,882 | -97.7% | 0.00% | -100.0% |
| Q3 2018 | $7,879,000 | +155.8% | 464,840 | +114.3% | 0.01% | +150.0% |
| Q2 2018 | $3,080,000 | -45.0% | 216,908 | -26.4% | 0.00% | -42.9% |
| Q1 2018 | $5,599,000 | +23.4% | 294,664 | +6.5% | 0.01% | +16.7% |
| Q4 2017 | $4,539,000 | -67.9% | 276,791 | -70.6% | 0.01% | -72.7% |
| Q3 2017 | $14,131,000 | +237.3% | 942,097 | +97.9% | 0.02% | +214.3% |
| Q2 2017 | $4,190,000 | +267.2% | 476,144 | +116.9% | 0.01% | +250.0% |
| Q1 2017 | $1,141,000 | +59.6% | 219,491 | -6.3% | 0.00% | +100.0% |
| Q4 2016 | $715,000 | -74.9% | 234,363 | -61.9% | 0.00% | -80.0% |
| Q3 2016 | $2,851,000 | -8.1% | 615,734 | +15.0% | 0.01% | -28.6% |
| Q2 2016 | $3,101,000 | +207.0% | 535,603 | +220.9% | 0.01% | +133.3% |
| Q1 2016 | $1,010,000 | -93.4% | 166,889 | -90.1% | 0.00% | -90.6% |
| Q4 2015 | $15,356,000 | +15.6% | 1,681,902 | -28.6% | 0.03% | +23.1% |
| Q3 2015 | $13,285,000 | +56.5% | 2,355,569 | +207.7% | 0.03% | +62.5% |
| Q2 2015 | $8,491,000 | -31.8% | 765,665 | -3.6% | 0.02% | -30.4% |
| Q1 2015 | $12,458,000 | +176.2% | 794,537 | +167.9% | 0.02% | +130.0% |
| Q4 2014 | $4,511,000 | -23.3% | 296,566 | -45.6% | 0.01% | -33.3% |
| Q3 2014 | $5,878,000 | +111.1% | 545,036 | +199.0% | 0.02% | +87.5% |
| Q2 2014 | $2,784,000 | +666.9% | 182,315 | +807.0% | 0.01% | +700.0% |
| Q1 2014 | $363,000 | -34.7% | 20,100 | -62.1% | 0.00% | -50.0% |
| Q3 2013 | $556,000 | +270.7% | 53,034 | +176.2% | 0.00% | – |
| Q2 2013 | $150,000 | – | 19,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |